top of page

Patient Support
Program Advantage

AI-driven PSP strategy to boost access, adherence, and commercial ROI.

Fractional 
Leadership
Deep Domain
Expertise
De-risk Commercialization

 
Clarity AI HITL Commercial Workflow 
Experienced Leadership
Team

Patient Support Programs 

​Strategic Growth AI is a commercialization and market access partner for pharmaceutical, biotech, and rare disease innovators ready to maximize the impact of their patient support programs (PSPs).
 
By combining AI-driven insights, regulatory mastery, and hands-on execution, we help you design, launch, and scale best-in-class patient support that boosts adherence, satisfies payers, and delivers measurable commercial impact. 

​

Patient Support Programs Have Evolved

​​The right Patient Support Program can accelerate therapy access, protect your revenue, and create lasting competitive advantage in today's specialty pharma landscape.

​

Patient Support Programs have evolved from "nice-to-have" engagement tools to essential revenue protection mechanisms that directly impact your bottom line.

​

Modern PSPs are battle-tested for specialty, rare, and high-cost medicines, delivering outcomes that matter to payers, providers, and patients alike.

  • 29% Higher Adherence

  • 22% Lower Discontinuation

  • $M Preserved Revenue

​​

From financial navigation to education and adherence support, PSPs handle the real-world complexity that blocks patients from optimal therapy outcomes.

strategicgrowthai patient support market

Complete Patient Journey Support

Rx Written

  • Prior authorization navigation

  • Financial assistance

Therapy Start

  • Device training

  • Initial education

Ongoing Support

  • Adherence monitoring

  • Nurse coaching

Outcomes Tracking

  • Real-world evidence

  • Value demonstration

Picture1.png

Concerns and Solutions to Adopting PSP

Concern: Regulatory & Compliance 

  • Patient data privacy 

  • Promotional optics 

  • Audit readiness

​

Solution:

  • Audit ready compliance built in

  • Continual monitoring

  • Neutral oversight

​​

Concern: ROI & Value Proof​

  • Attribution modelling

  • KPI dashboards

  • Budget impact models 

 

Solution

  • Positive Revenue Impact

  • Brand elongation

  • Patent cliff support

 

Concern: Integration & Scalability

  • EHR/CRM fragmentation

  • Scalability 

​

Solution

  • Built for Pharma systems

  • low lift

  • ongoing support

 

Concern: Internal Adoption Barriers

  • Cross-functional misalignment

  • Bandwidth 

​

Solution

  • Fractional Leadership

  • support

  • milestone governance

​

Concern: Fear of pilot fatigue ​

​

Solution

  • patient first branding

  • scalable rollout

  • omnichannel

​​

pateintr.png

Strategic Value for Pharmaceutical Firms

Real World Evidence

PSPs collect valuable data on outcomes, adherence, and side effects, demonstrating real-world effectiveness to payers and regulators.

Pharmacovigilance

Regular patient touchpoints help capture adverse events, fulfilling safety monitoring obligations and demonstrating proactive stance on drug safety.

Competitive Differentiation

In crowded markets, superior patient support can set a brand apart. For rare diseases and specialty drugs, robust PSPs are often considered "the cost of entry."

​​​​​​​​

Stakeholder Goodwill

PSPs demonstrate good corporate citizenship by helping patients achieve better health, improving company reputation with all stakeholders.

Board-Level Messaging

Patent Cliff Defense

Every patient kept persistent equals revenue shielded from generics. PSPs are not a bonus, but a business imperative for brands approaching loss of exclusivity.

Competitive Bench Marking

In most specialty therapeutic classes, category peers already run robust PSPs. Being the outlier risks lost market share and poor ratings among prescribers.

Market Access Pressures

Payers now require real-world evidence and outcomes data for favorable coverage decisions. PSPs generate this data and enable "bridge-to-listing" strategies.

Provider Demands

HCPs increasingly expect brands to support adherence operations and lower their administrative burden—programs that deliver this see higher prescription intent..

Stakeholder Messaging

​​

C-Suite

Protect revenue as products face generics and patent cliff

​

Market Access

Win payer buy in with real world outocomes 

​

Sales and Marketing

PSP's translate into higher market share and sales retention

​

​Legal and Compliance
Deploy audit ready and regionally compliant

​

IT and Digital

Seamless and compliant integration​

​​​

team.png

Why Strategic Growth AI

De-Risk Commercialization

 

Accelerate Time-to-Market

​

Embed AI-Driven Insights

 

Access On-Demand Expertise.

​

Deliver Audit-Ready Compliance

​

Micro-disclaimer:

Information is general and not a substitute for advice from qualified legal, regulatory, or medical professionals. Regulatory and payer outcomes are independent and not guaranteed. Clarity AI provides business scenario planning only.

​

Commercial Advantage & Patient Success

​​Transform your patient support from cost center to commercial advantage with enhanced patient outcomes

 

Strategic Growth AI's proven methodology, technology, and executive support deliver meaningful results, regulatory confidence, and sustained value for innovative pharma and biotech companies.

 

Eliminate delays, reduce risk, accelerate market impact and provide better patient outcomes.

​

Professional Affiliations

UBC Entrepreneurship   • BC Tech   • AIinBC   • Life Sciences BC

bottom of page